Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (surpass-1): A double-blind, randomised, phase 3 trial
Both are compounded medications, not the branded products, and your provider determines which medication and formulation is right for you in line with current FDA regulations
Under the Dietary Supplement Health and Education Act (DSHEA), these products can only make structure/function claims (not disease claims) and must carry a disclaimer stating that they have not been evaluated by the FDA
Legal status: Lipo-C is a compounded medication, meaning it's mixed by pharmacies according to specific formulations rather than manufactured as a standardized pharmaceutical product
Recent studies, including STEP-1 and SUSTAIN-8 clinical trials, have demonstrated that roughly 40% of the weight lost through GLP-1 injections is lean muscle mass, the very foundation of your metabolism
By binding with the DNA helicase Xeroderma pigmentosum group B (XPB), active p53 allows nucleotide excision repair and protects cells from chemotherapy-induced apoptosis